Conexeu Sciences, Inc. (CNXU)
7.07
+0.03
(+0.43%)
USD |
NASDAQ |
Aug 28, 16:00
7.04
-0.03
(-0.42%)
After-Hours: 04:20
Conexeu Sciences Debt to Equity Ratio : 0.00 for April 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| April 30, 2026 | 0.00 |
| January 31, 2026 | |
| October 31, 2025 |
| Date | Value |
|---|---|
| April 30, 2025 | |
| October 31, 2024 | 1.033 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AbbVie, Inc. | -11.93 |
| Vericel Corp. | 0.2556 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 8.200M |
| Total Liabilities (Quarterly) | 1.003M |
| Shareholders Equity (Quarterly) | 7.196M |
| Current Ratio | 7.888 |